The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 383.50
Bid: 388.00
Ask: 390.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.515%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 383.50
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Information on Santander Dividendo Eleccion

7 Nov 2018 07:00

RNS Number : 5548G
Banco Santander S.A.
06 November 2018
 

 

 

 

 

 

MATERIAL FACT

 

 

Further to the material fact communication dated October 16, 2018 (registry number 270,543), Banco Santander, S.A. ("Banco Santander") announces that the trading period for the bonus share rights corresponding to the capital increase with a charge to reserves (the "Capital Increase") through which the "Santander Dividendo Elección" scheme is carried out ended on November 1, 2018.

 

The holders of 76.55% of the bonus share rights have chosen to receive new shares. Thus, the definitive number of ordinary shares of 0.5 Euros of face value issued in the Capital Increase is 100,420,360, equivalent to 0.62% of the share capital, and the amount of the Capital Increase is 50,210,180 Euros. After the Capital Increase, the share capital amounts to 8,118,286,971 Euros represented by 16,236,573,942 ordinary shares of 0.5 Euros of face value each. The value of the compensation corresponding to the holders of bonus share rights who have requested new shares amounts to 432,309,649.80 Euros.

 

The shareholders holding the remaining 23.45% of the bonus share rights have accepted the irrevocable commitment to purchase bonus share rights assumed by Banco Santander. Consequently, Banco Santander has acquired 3,784,449,227 rights for a total gross consideration of 132,455,722.95 Euros. Banco Santander has waived the bonus share rights so acquired.

 

It is envisaged that the relevant authorisations for the admission to listing of the new shares in the Spanish Stock Exchanges will be granted on November 13, 2018. As a result, ordinary trading of these shares will commence in Spain on November 14[1]. The authorisation for the admission to listing of those shares will also be requested on all other stock exchanges on which Banco Santander is listed.

 

 

Boadilla del Monte (Madrid), November 6, 2018

 


[1] Estimated date. Subject to the granting of the relevant authorisations.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDLFFILLFLRIIT
Date   Source Headline
24th Apr 20237:00 amRNSEnd of the Programme & 19-21 April Transactions
19th Apr 202311:22 amRNSBuyback programme: transactions 12 - 18 April
18th Apr 202311:26 amRNSNotice of First Quarter 2023 Results
12th Apr 202311:04 amRNSBuyback programme: transactions 30 March -11 April
11th Apr 20237:00 amRNSFurther re Santander Mexico tender offer: results
31st Mar 20232:28 pmRNS2023 AGM - Resolutions
31st Mar 202312:11 pmRNSTotal Voting Rights
31st Mar 20237:35 amRNSSantander to confirm its targets for 2023 at AGM
30th Mar 202311:05 amRNSBuyback programme: transactions 23 - 29 March
23rd Mar 202311:40 amRNSDirector/PDMR Shareholding
23rd Mar 202310:22 amRNSBuyback programme: transactions 16 - 22 March
21st Mar 20231:04 pmRNSFurther re capital reduction
17th Mar 202312:21 pmRNSDirector/PDMR Shareholding
16th Mar 20235:16 pmRNSTotal Voting Rights
16th Mar 202311:18 amRNSCapital reduction (buy-back programme shares)
16th Mar 202311:09 amRNSBuyback programme: transactions 9 - 15 March
10th Mar 20239:55 amRNS2022 UK Annual Report
9th Mar 20234:27 pmRNSDirector/PDMR Shareholding
9th Mar 202311:39 amRNSBuyback programme: transactions 1 - 8 March
6th Mar 20233:02 pmRNSDirector/PDMR Shareholding
6th Mar 20232:59 pmRNSDirector/PDMR Shareholding
28th Feb 20235:27 pmRNSNotice of AGM
28th Feb 202312:23 pmRNSTotal Voting Rights
28th Feb 20239:51 amRNSInvestor Day: Group CFO presentation
28th Feb 20238:33 amRNSInvestor Day: Group CEO presentation
28th Feb 20238:05 amRNSInvestor Day: Executive chair presentation
28th Feb 20237:00 amRNSPayout policy, strategic plans & profit forecasts
28th Feb 20237:00 amRNSExecution of 2022 shareholder remuneration policy
24th Feb 20237:00 amRNSDirector/PDMR Shareholding
21st Feb 202310:58 amRNSInvestor Day meeting announcement
17th Feb 20231:33 pmRNSDirector/PDMR Shareholding
7th Feb 202311:24 amRNSTender Offer
2nd Feb 20237:00 amRNS2022 Financial report & Earnings presentation
2nd Feb 20237:00 amRNS2022 Results - Press release
1st Feb 202311:06 amRNSEnd of the Programme & 26 -31 Jan Transactions
31st Jan 20233:22 pmRNSTotal Voting Rights
26th Jan 202311:08 amRNSNotice of 2022 Results
26th Jan 202311:03 amRNSBuyback programme: transactions 19 - 25 January
19th Jan 202311:14 amRNSBuyback programme: transactions 12 - 18 January
12th Jan 202311:29 amRNSBuyback programme: transactions 5 - 11 January
5th Jan 202311:14 amRNSBuyback programme: transactions 29 Dec- 4 Jan
30th Dec 202212:18 pmRNSTotal Voting Rights
29th Dec 202211:06 amRNSBuyback programme: transactions 21- 28 December
28th Dec 20227:00 amRNSTotal Voting Rights
28th Dec 20227:00 amRNSDirector/PDMR Shareholding
28th Dec 20227:00 amRNSDirector/PDMR Shareholding
23rd Dec 202211:33 amRNSTotal early redemption of mortgage covered bonds
22nd Dec 202210:17 amRNSSREP Capital Requirements 2023
21st Dec 20224:59 pmRNSDirector/PDMR Shareholding
21st Dec 202211:14 amRNSBuyback programme: transactions 12- 20 December

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.